Continuous positive airway pressure devices for the treatment of obstructive sleep apnoea-hypopnoea syndrome: A systematic review and economic analysis

Health Technology Assessment

Volumn 13, Issue 4, 2009, Pages

  McDaid, C ^a   Griffin, S ^a   Weatherly, H ^a   Duree K ^a   van der Burgt, M ^a   van Hout, S ^a   Akers, J ^a   Davies, R J O ^b   Sculpher, M ^a   Westwood, M ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

^b OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COGNITION; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DAYTIME SOMNOLENCE; DENTAL DEVICE; DISEASE SEVERITY; ECONOMIC EVALUATION; EPWORTH SLEEPINESS SCALE; HEALTH CARE UTILIZATION; HUMAN; MEAN ARTERIAL PRESSURE; POSITIVE END EXPIRATORY PRESSURE; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SAFETY; SLEEP APNEA SYNDROME; SYSTEMATIC REVIEW; TRAFFIC ACCIDENT; BIOMEDICAL TECHNOLOGY ASSESSMENT; COST BENEFIT ANALYSIS; ECONOMICS; EQUIPMENT; META ANALYSIS; PATHOPHYSIOLOGY; PHARYNGEAL MUSCLE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SLEEP DISORDERED BREATHING; STATISTICAL MODEL; TREATMENT OUTCOME;

CONTINUOUS POSITIVE AIRWAY PRESSURE; COST-BENEFIT ANALYSIS; DENTAL DEVICES, HOME CARE; HUMANS; MODELS, ECONOMIC; PHARYNGEAL MUSCLES; QUALITY-ADJUSTED LIFE YEARS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SLEEP APNEA SYNDROMES; SLEEP APNEA, OBSTRUCTIVE; TECHNOLOGY ASSESSMENT, BIOMEDICAL; TREATMENT OUTCOME;

EID: 84964473140     PISSN: 13665278     EISSN: None     Source Type: Journal    
DOI: 10.3310/hta13040     Document Type: Article

References (349)

1. Stradling JR, Davies RJ. Sleep 1: Obstructive sleep apnoea/hypopnoea syndrome: definitions, epidemiology, and natural history. Thorax 2004;59:73-8.
2. Douglas NJ, Polo O. Pathogenesis of obstructive sleep apnoea/hypopnoea syndrome. Lancet 1994;344:653-5.
3. Gibson GJ, Douglas NJ, Stradling JR, London DR, Semple SJ. Sleep apnoea: clinical importance and facilities for investigation and treatment in the UK: addendum to the 1993 Royal College of Physicians sleep apnoea report. J R Coll Physicians Lond 1998;32:540-4.
4. Gibson GJ. Obstructive sleep apnoea syndrome: underestimated and undertreated. Br Med Bull 2004;72:49-64.
5. Sleep related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999;22:667-89.
6. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540-5.
7. Johns MW. Reliability and factor analysis of the Epworth sleepiness scale. Sleep 1992;15:376-81.
8. Arand D, Bonnet M, Hurwitz T, Mitler M, Rosa R, Sangal RB. The clinical use of the MSLT and MWT. Sleep 2005;28:123-44.
9. Krieger AC, Ayappa I, Norman RG, Rapoport DM, Walsleben J. Comparison of the maintenance of wakefulness test (MWT) to a modified behavioral Lest (OSLER) in the evaluation of daytime sleepiness. J Sleep Res 2004;13:407-11.
10. Bennett LS, Langford BA, Stradling JR, Davies RJ. Sleep fragmentation indices as predictors of daytime sleepiness and nCPAP response in obstructive sleep apnea. Am J Respir Crit Care Med 1998; 158:778-86.
11. Davies RJ, Stradling JR. The epidemiology of sleep apnoea. Thorax 1996;51:S65-70.
12. Engleman HM, Douglas NJ. Sleep. 4: Sleepiness, cognitive function, and quality of life in obstructive sleep apnoea/hypopnoea syndrome. Thorax 2004;59:618-22.
13. Wright J, Johns R, Watt I, Melville A, Sheldon T. Health effects of obstructive sleep apnoea and the effectiveness of continuous positive airways pressure: a systematic review of the research evidence. BMJ 1997;314:851-60.
14. Boland LL, Shahar E, Iber C, Knopman DS, Kuo TF, Nieto FJ, et al. Measures of cognitive function in persons with varying degrees of sleep-disordered breathing: the Sleep Heart Health Study. J Sleep Res 2002;11:265-72.
15. Saunamaki T, Jehkonen M. A review of executive functions in obstructive sleep apnea syndrome. Acta Neurol Scand 2007;115:1-11.
16. Engleman HM, Douglas NJ. Sleep, driving and the workplace. Clin Med 2005;5:113-17.
17. Hack MA, Choi SJ, Vijayapalan P, Davies RJ, Stradling JR. Comparison of the effects of sleep deprivation, alcohol and obstructive sleep apnoea (OSA) on simulated steering performance. Respir Med 2001; 95:594-601.
18. George CF, Boudreau AC, Smiley A. Simulated driving performance in patients with obstructive sleep apnea. Am J Respir Crit Care Med 1996;154:175-81.
19. Sassani A, Findley LJ, Kryger M, Goldlust E, George C, Davidson TM. Reducing motor-vehicle collisions, costs, and fatalities by treating obstructive sleep apnea syndrome. Sleep 2004;27:453-8.
20. Moyer CA, Sonnad SS, Garetz SL, Helman JI, Chervin RD. Quality of life in obstructive sleep apnea: a systematic review of the literature. Sleep Med 2001;2:477-91.
21. Shipper H, Clinch J, Powell V. Definition and conceptual issues. In Spilker B, editor. Quality of life assessments in clinical trials. New York, NY: Raven Press; 1990. pp. 11-24.
22. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 health survey: manual and interpretation guide. Lincoln, RI: QualityMetric Inc; 2000.
23. Hunt SM, McEwen J, McKenna SP. Measuring health status: a new tool for clinicians and epidemiologists. J R Coll Gen Pract 1985; 35:185-8.
24. The EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990; 16:199-208.
25. Weaver TE, Laizner AM, Evans LK, Maislin G, Chugh DK, Lyon K, et al. An instrument to measure functional status outcomes for disorders of excessive sleepiness. Sleep 1997;20:835-43.
26. Flemons WW, Reimer MA. Development of a disease-specific health-related quality of life questionnaire for sleep apnea. Am J Respir Crit Care Med 1998;158:494-503.
27. McNicholas WT, Bonsignore MR, the Management Committee of EU Cost Action B26. Sleep apnoea as an independent risk factor for cardiovascular disease. Current evidence, basic mechanisms and research priorities. Eur Respir J 2007;29:156-78.
28. Shamsuzzaman AS, Gersh BJ, Somers VK. Obstructive sleep apnea: implications for cardiac and vascular discase. JAMA 2003; 290:1906-14.
29. Robinson GV, Stradling JR, Davies RJ. Sleep 6: Obstructive sleep apnoea/ hypopnoea syndrome and hypertension. Thorax 2004; 59:1089-94.
30. Shneerson J, Wright J. Lifestyle modification for obstructive sleep apnoea. Cochrane Database of Systematic Reviews 2001;1:Art. No.: CD002875. DOI:10.1002/14651858.CD002875.
31. Smith I, Lasserson TJ, Wright J. Drug therapy for obstructive sleep apnoea in adults. Cochrane Database of Systematic Reviews 2006; 2:Art. No.: CD003002. DOI:10.1002/14651858.CD003002.pub2.
32. Sundaram S, Bridgman SA, Lim J, Lasserson TJ. Surgery for obstructive sleep apnoea. Cochrane Database of Systematic Reviews 2005; 4:Art. No.: CD001004. DOI:10.1002/14651858.CD001004.pub2.
33. Chong MS, Ayalon L, Marler M, Loredo JS, Corey-Bloom J, Palmer BW, et al. Continuous positive airway pressure reduces subjective daytime sleepiness in patients with mild to moderate Alzheimer's disease with sleep disordered breathing. J Am Geriatr Soc 2006; 54:777-81.
34. 2 on the susceptibility to posthyperventilation apnea during sleep. J Appl Physiol 2006;100:171-7.
35. Nadar S, Prasad N, Taylor RS, Lip GY. Positive pressure ventilation in the management of acute and chronic cardiac failure: a systematic review and meta-analysis. Int J Cardiol 2005;99:171-85.
36. Ryan CM, Usui K, Floras JS, Bradley TD. Effect of continuous positive airway pressure on ventricular ectopy in heart failure patients with obstructive sleep apnoea. Thorax 2005;60:781-5.
37. Haniffa M, Lasserson TJ, Smith I. Interventions to improve compliance with continuous positive airway pressure for obstructive sleep apnoea. Cochrane Database of Systematic Reviews 2004;4:Art. No.: CD003531. DOI:10.1002/14651858.CD003531.pub2.
38. Popescu G, Latham M, Allgar V, Elliott MW. Continuous positive airway pressure for sleep apnoea/hypopnoea syndrome: usefulness of a 2 week trial to identify factors associated with long term use. Thorax 2001;56:727-33.
39. McArdle N, Devereux G, Heidarnejad H, Engleman HM, Mackay TW, Douglas NJ. Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999;159:1108-14.
40. Krieger J, Kurtz D, Petiau C, Sforza E, Trautmann D. Long-term compliance with CPAP therapy in obstructive sleep apnea patients and in snorers. Sleep 1996;19:S136-43.
41. Martins dc Araujo MT, Vieira SB, Vasquez EC, Fleury B. Heated humidification or face mask to prevent upper airway dryness during continuous positive airway pressure therapy. Chest 2000; 117:142-7.
42. Hailey D, Jacobs P, Mayers I, Mensinkai S. The current status of autotitrating continuous positive airway pressure systems in the management of obstructive sleep apnea. Can Respir J 2005; 12:271-6.
43. Chai CL, Pathinathan A, Smith B. Continuous positive airway pressure delivery interfaces for obstructive sleep apnoea. Cochrane Database of Systematic Reviews 2006;4:Art. No.: CD005308. DOI: 10.1002/ 14651858.CD005308.pub2.
44. Chilcott J, Clayton E, Chada N, Hanning CD, Kinnear W, Waterhouse JC. Nasal continuous positive airways pressure in the management of sleep apnoea. Leicester: Trent Institute for Health Services Research; 2000.
45. Hoekema A, Stegenga B, De Bont LG. Efficacy and co-morbidity of oral appliances in the treatment of obstructive sleep apnea-hypopnea: a systematic review. Crit Rev Oral Biol Med 2004;15:137-55.
46. Ferguson KA, Cartwright R, Rogers R, Schmidt-Nowara W. Oral appliances for snoring and obstructive sleep apnea: a review. Sleep 2006; 29:244-62.
47. Kushida CA, Morgenthaler TI, Littner MR, Alessi CA, Bailey D, Coleman J, et al. Practice parameters for the treatment of snoring and obstructive sleep apnea with oral appliances: an update for 2005. Sleep 2006;29:240-3.
48. Marshall NS, Barnes M, Travier N, Campbell AJ, Pierce RJ, McEvoy RD, et al. Continuous positive airway pressure reduces daytime sleepiness in mild to moderate obstructive sleep apnoea: a meta-analysis. Thorax 2006;61:430-4.
49. Patel SR, White DP, Malhotra A, Stanchina ML, Ayas NT. Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: results of a meta-analysis. Arch Intern Med 2003;163:565-71.
50. Giles TL, Lasserson TJ, Smith BJ, White J, Wright J, Cates CJ. Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database of Systematic Reviews 2006;3:Art. No.: CD001106. DOI:10.1002/14651858.CD001106.pub3.
51. Curtin E, Altman DG, Elbourne D. Meta-analysis combining parallel and cross-over clinical trials. I: continuous outcomes. Stat Med 2002;21:2131-44.
52. Elbourne DR, Altman DG, Higgins JPT, Curtin F, Worthington HV, Vail A. Meta-analyses involving cross-over trials: methodological issues. Int J Epidemiol 2002;31:140-9.
53. Lim J, Lasserson TJ, Fleetham J, Wright J. Oral appliances for obstructive sleep apnoea. Cochrane Database of Systematic Reviews 2006;1:Art. No.: CD004435. DOI:10.1002/14651858.CD004435.pub3.
54. Higgins J, Green S, editors. Cochrane handbook for systematic reviews of interventions 4.2.6 [updated Sept. 2006]. 2006. [cited 2007 23 May]. URL: www.cochrane.dk/cochrane/handbook/handbook.htm.
55. Vickers AJ, Altman DG. Analysing controlled trials with baseline and follow up measurements. BMJ 2001;323:1123-4.
56. Arias MA, Garcia-Rio F, Alonso-Fernandez A, Mediano O, Martinez I, Villamor J. Obstructive sleep apnea syndrome affects left ventricular diastolic function: effects of nasal continuous positive airway pressure in men. Circulation 2005;112:375-83.
57. Higgins JPT, Thompson SG, Decks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
58. Dimsdale JE, Loredo JS, Profant J. Effect of continuous positive airway pressure on blood pressure: a placebo trial. Hypertension 2000; 35:144-7.
59. Redline S, Adams N, Strauss ME, Roebuck T, Winters M, Rosenberg C. Improvement of mild sleep-disordered breathing with CPAP compared with conservative therapy. Am J Respir Crit Care Med 1998; 157:858-65.
60. Skinner MA, Kingshott RN, Jones DR, Homan SD, Taylor DR. Elevated posture for the management of obstructive sleep apnea. Sleep Breath 2004;8:193-200.
61. Skinner MA, Kingshott RN, Jones DR, Taylor DR. Lack of efficacy for a cervicomandibular support collar in the management of obstructive sleep apnea. Chest 2004;125:118-26.
62. Coughlin SR, Mawdsley L, Mugarza JA, Wilding JPH, Calverley PM. Cardiovascular and metabolic effects of CPAP in obese men with OSA [epub ahead of print]. Eur Respir J 2007. DOI:10.1183/09031936.0043306.
63. Arias MA, Garcia-Rio F, Alonso-Fernandez A, Martinez I, Villamor J. Pulmonary hypertension in obstructive sleep apnoea: effects of continuous positive airway pressure. A randomized, controlled cross-over study. Eur Heart J 2006;27:1106-13.
64. Hui DS, To KW, Ko FW, Fok JP, Chan MC, Ngai JC, et al. Nasal CPAP reduces systemic blood pressure in patients with obstructive sleep apnoea and mild sleepiness. Thorax 2006;61:1083-90.
65. Campos-Rodriguez F, Grilo-Reina A, Perez-Ronchel J, Merino-Sanchez M, Gonzalez-Benitez MA, Beltran-Robles M, et al. Effect of continuous positive airway pressure on ambulatory BP in patients with sleep apnea and hypertension: a placebo-controlled trial. Chest 2006; 129:1459-67.
66. Spicuzza L, Bernardi L, Balsamo R, Ciancio N, Polosa R, Di Maria G. Effect of treatment with nasal continuous positive airway pressure on ventilatory response to hypoxia and hypercapnia in patients with sleep apnea syndrome. Chest 2006;130:774-9.
67. West SD, Nicoll DJ, Wallace TM, Matthews DR, Stradling JR. The effect of CPAP on insulin resistance and HBA1C in people with obstructive sleep apnoea and type 2 diabetes: a randomised controlled trial. Thorax 2006;61(Suppl. 2):ii54.
68. Robinson GV, Smith DM, Langford BA, Davies RJ, Stradling JR. Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients. Eur Respir J 2006;27:1229-35.
69. Drager LF, Bortolotto LA, Figueiredo AC, Krieger EM, Lorenzi-Filho G. Continuous positive airway pressure therapy reverses the impaired arterial stiffness in normotensive patients with obstructive sleep apnea. Sleep Med 2006;7:S14.
70. Lam B, Sam K, Mok W, Cheung MT, Fong DY, Lam JC, et al. A randomised study of three non-surgical treatments in mild to moderate obstructive sleep apnoea. Thorax 2007;62:354-9.
71. Hoekema A. Efficacy and comorbidity of oral appliances in the treatment of obstructive sleep apnea-hypopnea: a systematic review and preliminary results of a randomized trial. Sleep Breath 2006;10:102-3.
72. Cibele D-F, Garbuio SA, D'Almeida V, Santos RF, Bittencourt LR, Tufik S. Efficacy of an oral appliance (OA) compared with nCPAP over oxidative stress parameters in obstructive sleep apnea (OSA) patients: preliminary results. Sleep Med 2006;7:S93.
73. Norman D, Loredo JS, Nelesen RA, Ancoli-Israel S, Mills PJ, Ziegler MG, et al. Effects of continuous positive airway pressure versus supplemental oxygen on 24-hour ambulatory blood pressure. Hypertension 2006;47:840-5.
74. Egea C, Pinto J, Ayuela J, Ballester E, Zamarron C, Sojo A, et al. Efficacy of the treatment with CPAP in patients with chronic heart failure and sleep apnoea. Eur Respir J 2004;24:S564
75. Kaneko Y, Floras JS, Usui K, Plante J, Tkacova R, Kubo T, et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003;348:1233-41.
76. Mansfield DR, Gollogly NC, Kaye DM, Richardson M, Bergin P, Naughton MT. Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med 2004; 169:361-6.
77. Jenkinson C, Davies RJ, Mullins R, Stradling JR. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet 1999;353:2100-5.
78. Engleman HM, Kingshott RN, Wraith PK, Mackay TW. Deary IJ, Douglas NJ. Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999;159:461-7.
79. Marshall NS, Neill AM, Campbell AJ, Sheppard DS. Randomised controlled crossover trial of humidified continuous positive airway pressure in mild obstructive sleep apnoea. Thorax 2005;60:427-32.
80. Ferguson KA, Ono T, Lowe AA, al Majed S, Love LL, Fleetham JA. A short-term controlled trial of an adjustable oral appliance for the treatment of mild to moderate obstructive sleep apnoea. Thorax 1997;52:362-8.
81. Ferguson KA, Ono T, Lowe AA, Keenan SP, Fleetham JA. A randomized crossover study of an oral appliance vs nasal-continuous positive airway pressure in the treatment of mild-moderate obstructive sleep apnea. Chest 1996;109:1269-75.
82. Barnes M, McEvoy RD, Banks S, Tarquinio N, Murray CG, Vowles N, et al. Efficacy of positive airway pressure and oral appliance in mild to moderate obstructive sleep apnea. Am J Respir Crit Care Med 2004;170:656-64.
83. Barbé F, Mayoralas LR, Duran J, Masa JF, Maimo A, Montserrat JM, et al. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. a randomized, controlled trial. Ann Intern Med 2001; 134:1015-23.
84. Becker HF, Jerrentrup A, Ploch T, Grote L, Penzel T, Peter JH. Effect of therapeutic and subtherapeutic nasal continuous positive airway pressure (nCPAP) treatment on blood pressure in obstructive sleep apnea (OSA). Sleep Med 2003;4:S3.
85. Henke KG, Grady JJ, Kuna ST. Effect of nasal continuous positive airway pressure on neuropsychological function in sleep apnea-hypopnea syndrome. A randomized, placebo-controlled trial. Am J Respir Crit Care Med 2001;163:911-17.
86. Montserrat JM, Ferrer M, Hernandez L, Farre R, Vilagut G, Navajas D, et al. Effectiveness of CPAP treatment in daytime function in sleep apnea syndrome: a randomized controlled study with an optimized placebo. Am J Respir Crit Care Med 2001;164:608-13.
87. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, Mullins R, Jenkinson C, Stradling JR, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2002;359:204-10.
88. Cross MD, Al-Abri M, Newby DE, Riha R, Vennelle M, Douglas NJ. RCT evidence that CPAP improves endothelial function in obstructive sleep apnea-hypopnea syndrome (OSAHS). In American Thoracic Society International Conference; 2005 May 20-25; San Diego, California. American Thoracic Society; 2005, p. A87. URL: www.abstracts2view.com/ ats05/.
89. Barnes M, Houston D, Worsnop CJ, Neill AM, Mykytyn IJ, Kay A, et al. A randomized controlled trial of continuous positive airway pressure in mild obstructive sleep apnea. Am J Respir Crit Care Med 2002; 165:773-80.
90. Engleman HM, Martin SE, Deary IJ, Douglas NJ. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/ hypopnoea syndrome. Lancet 1994;343:572-5.
91. Engleman HM, Gough K, Martin SE, Kingshott RN, Padfield PL, Douglas NJ. Ambulatory blood pressure on and off continuous positive airway pressure therapy for the sleep apnea/hypopnea syndrome: effects in "non-dippers". Sleep 1996;19:378-81.
92. Engleman HM, Martin SE, Deary IJ, Douglas NJ. Effect of CPAP therapy on daytime function in patients with mild sleep apnoea/hypopnoea syndrome. Thorax 1997;52:114-9.
93. Engleman HM, Martin SE, Kingshott RN, Mackay TW, Deary IJ, Douglas NJ. Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome. Thorax 1998;53:341-5.
94. Faccenda JF, Mackay TW, Boon NA, Douglas NJ. Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 2001;163:344-8.
95. McArdle N, Douglas NJ. Effect of continuous positive airway pressure on sleep architecture in the sleep apnea-hypopnea syndrome: a randomized controlled trial. Am J Respir Crit Care Med 2001; 164:1459-63.
96. Ballester E, Badia JR, Hernandez L, Carrasco E, de Pablo J, Fornas C, et al. Evidence of the effectiveness of continuous positive airway pressure in the treatment of sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999;159:495-501.
97. Chakravorty I, Cayton RM, Szczepura A. Health utilities in evaluating intervention in the sleep apnoea/hypopnoea syndrome. Eur Respir J 2002;20:1233-8.
98. Lim LL. Effect of CPAP therapy on pain, disability and quality of life in chronic daily headache and sleep apnea: a randomized controlled trial. Neurology 2005;64:A24.
99. Lojander J, Maasilta P, Partinen M, Brander PE, Salmi T, Lehtonen H. Nasal-CPAP, surgery, and conservative management for treatment of obstructive sleep apnea syndrome. A randomized study. Chest 1996;110:114-9.
100. Monasterio C, Vidal S, Duran J, Ferrer M, Carmona C, Barbé F, et al. Effectiveness of continuous positive airway pressure in mild sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 2001; 164:939-43.
101. Fleetham JA, Lowe A, Vazquez JC, Ferguson K, Flemons W, Remmers JA. A long term randomized parallel multicentre study of an oral appliance vs nCPAP in the treatment of obstructive sleep apnea. Am J Respir Crit Care Med 2002.
102. Hoekema A, Stegenga B, Wijkstra H, van der Hoeven JH, Meinesz AF, de Bont LG. Effectiveness of obstructive sleep apnea therapy: a randomized parallel clinical trial of oral-appliance versus continuous positive airway pressure therapy. Sleep Med 2006;7:S14.
103. Engleman HM, McDonald JP, Graham D, Lello GE, Kingshott RN, Coleman EL, et al. Randomized crossover trial of two treatments for sleep apnea/hypopnea syndrome: continuous positive airway pressure and mandibular repositioning splint. Am J Respir Crit Care Med 2002; 166:855-9.
104. L'Estrange PR, Smith C, Grant HR, Makker HK, Spiro SG. Pilot randomised trial of nasal continuous positive airway pressure (CPAP) ventilation versus a mandibular advancement splint (MAS) in severe obstructive sleep apnoea (OSA): early difficulties. In European Respiratory Society; 1999 Oct 9-13; Madrid, Spain. European Respiratory Society; 1999. p. P2701.
105. Randerath WJ, Heise M, Hinz R, Ruehle KH. An individually adjustable oral appliance vs continuous positive airway pressure in mild-to-moderate obstructive sleep apnea syndrome. Chest 2002; 122:569-75.
106. Tan YK, L'Estrange PR, Luo YM, Smith C, Grant HR, Simonds AK, et al. Mandibular advancement splints and continuous positive airway pressure in patients with obstructive sleep apnoea: a randomized cross-over trial. Eur J Orthod 2002;24:239-49.
107. Olson LG, Ambrogetti A, Trevillian Z. A randomised crossover comparison of nasal CPAP and a mandibular advancement splint in mild obstructive steep apnea. 2002 [unpublished data reproduced in Cochrane Review CD001106].
108. Jokic R, Klimaszewski A, Crossley M, Sridhar G, Fitzpatrick MF. Positional treatment vs continuous positive airway pressure in patients with positional obstructive sleep apnea syndrome. Chest 1999; 115:771-81.
109. Becker HF, Jerrentrup A, Ploch T, Grote L, Penzel T, Sullivan CE, et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003;107:68-73.
110. Lim LL. Effect of CPAP therapy on pain, disability and quality of life in chronic daily headache and sleep apnea: a randomized controlled trial. Neurology 2005;64:A422-3.
111. Hoekema A, Stel A-L, Stegenga B, van der Hoeven JH, Wijkstra PJ, van Driel F, et al. Sexual function and obstructive sleep apnea-hypopnea: a randomized clinical trial evaluating the effects of oral-appliance and continuous positive airway pressure therapy. J Sex Med (Online Early Articles); 2006. DOI:10.1111/ j.743-6109.2006.00341.x.
112. Engleman HM, Carruthers ER, Kingshott RN, McArdle N, Faccenda JF, Douglas NJ. Randomized trial of MRS vs CPAP therapy for the sleep apnea/ hypopnea syndrome (SAHS). Am J Respir Crit Care Med 1999; 159:A248.
113. Lojander J, Kajaste S, Maasilta P, Partinen M. Cognitive function and treatment of obstructive sleep apnea syndrome. J Sleep Res 1999; 8:71-6.
114. Hoekema A, Stegenga B, Bakker M, Brouwer WH, de Bont LG, Wijkstra H, et al. Simulated driving in obstructive sleep apnoea-hypopnoea; effects of oral appliances and continuous positive airway pressure. Sleep Breath 2007. DOI:10.1007/s11325-006-0093-7.
115. Lezak MD. Neuropsychological assessment. 3rd ed n. New York: Oxford University Press; 1995.
116. Lim W, Bardwell WA, Loredo JS, Kim E, Ancoli-Israel S, Dimsdale JE. Effects of two-week continuous positive airway pressure treatment and supplemental oxygen on neuropsychological functioning in patients with obstructive sleep apnea: a randomized placebo-controlled study. Sleep 2005;28:A172.
117. Bardwell WA, Ancoli-Israel S, Berry CC, Dimsdale JE. Neuropsychological effects of one-week continuous positive airway pressure treatment in patients with obstructive sleep apnea: a placebo-controlled study. Psychosom Med 2001;63:579-84.
118. Hack M, Davies RJ, Mullins R, Choi SJ, Ramdassingh-Dow S, Jenkinson C, et al. Randomised prospective parallel trial of therapeutic versus subtherapeutic nasal continuous positive airway pressure on simulated steering performance in patients with obstructive sleep apnoea. Thorax 2000;55:224-31.
119. Land M, Horwood J. Which parts of the road guide steering? Nature 1995;377:339-40.
120. Fleetham JA, Lowe A, Vazquez JC, Ferguson K, Flemons W, Remmers JA. A long term randomized parallel multicentre study of an oral appliance vs nCPAP in the treatment of obstructive sleep apnoea. Am J Respir Crit Care Med 1998;Suppl. D:A939.
121. ResMed. Cost-effectiveness and cost-utility of using continuous positive airways pressure in the treatment of severe obstructive sleep apnoea/hypopnoea syndrome in the UK. ResMed submission for CPAP technology appraisal. Abingdon: ResMed (UK); 2007.
122. Drummond M, Sculpher M, Torrance G, O'Brien BJ, Stoddart GL. Methods for the economic evaluation of health care programmes. 3rd edn. Oxford: Oxford University Press; 2005.
123. Ayas NT, FitzGerald JM, Fleetham JA, White DP, Schulzer M, Ryan CF, et al. Cost-effectiveness of continuous positive airway pressure therapy for moderate to severe obstructive sleep apnea/hypopnea. Arch Intern Med 2006;166:977-84.
124. Mar J, Rueda JR, Duran-Cantolla J, Schechter C, Chilcott J. The cost-effectiveness of nCPAP treatment in patients with moderate-to-severe obstructive sleep apnoea. Eur Respir J 2003; 21:515-22.
125. Tousignant P, Cosio MG, Levy RD, Groome PA. Quality adjusted life years added by treatment of obstructive sleep apnea. Sleep 1994; 17:52-60.
126. Fisher & Paykel Healthcare. Continuous positive airways pressure (CPAP) for the treatment of obstructive sleep apnoea/hypopnoea syndrome (OSAHS). MTA submission to the National Institute for Health and Clinical Excellence. Maidenhead: Fisher & Paykel Healthcare; 2007.
127. Respironics (UK) Ltd. Continuous positive airway pressure treatment for obstructive sleep apnoea/hypopnoea syndrome (OSAHS). Submission to the National Institute for Health and Clinical Excellence. Chichester: Respironics (UK) Ltd; 2007.
128. EuroQoL Group. EuroQoL - A new facility for measurement of health-related quality of life. Health Policy 1990; 16:199-208.
129. Dolan P, Gudex C, Kind P, Williams A. The time trade-off method: results from a general population study. Health Econ 1996;5:141-54.
130. Torrance GW, Feeny D. Utilities and quality-adjusted life years. Int J Technol Assess Health Care 1989;5:559-75.
131. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005;365:1046-53.
132. George CF. Reduction in motor vehicle collisions following treatment of sleep apnoea with nasal CPAP. Thorax 2001;56:508-12.
133. Mazza S, Pepin JL, Naegele B, Rauch E, Deschaux C, Ficheux P, et al. Driving ability in sleep apnoea patients before and after CPAP treatment: evaluation on a road safety platform. Eur Respir J 2006;28:1020-8.
134. Department of Transport. Highways economic note No.1 [web page]. Department of Transport; 2004. [cited 2007 9 May]. URL: www.dft.gov.uk/ pgr/roadsafety/ea/highwayseconomicnoteno 12004.
135. Findley L, Smith C, Hooper J, Dineen M, Suratt PM. Treatment with nasal CPAP decreases automobile accidents in patients with sleep apnea. Am J Respir Crit Care Med 2000;161:857-9.
136. Marquez-Baez C, Paniagua-Soto J, Castilla-Garrido JM. Treatment of sleep apnea syndrome with CPAP: compliance with treatment, its efficacy and secondary effects. Rev Neurol 1998;26:375-80.
137. Department of Health. NHS reference costs 2005-06. Department of Health; 2006. URL: www.dh.gov.uk/PublicationsAndStatistics/Publications/ PublicationsPolicyAndGuidance/PublicationsPolicyAndGuidanceArticle/fs/ en?CONTENT_ID=4141135&chk=7wrsFg.
138. Taylor RS, Watt A, Dalda HM, et al. Home-based cardiac rehabilitation versus hospital-based rehabilitation: a cost-effectiveness analysis. Int J Cardiol 2006 [Epub ahead of print].
139. Department of Health. Reducing brain damage: faster access to better stroke care. National Audit Office; November 2005.
140. Krieger J, Meslier N, Lebrun T, Levy P, Phillip-Joet F, Sailly JC, et al. Accidents in obstructive sleep apnea patients treated with nasal continuous positive airway pressure: a prospective study. Chest 1997;112:1561-6.
141. Findley LJ, Unverzagt ME, Suratt PM. Automobile accidents involving patients with obstructive sleep apnea. Am Rev Respir Dis 1988; 138:337-40.
142. Engleman H, Asgari-Jihandeh N, McLeod L, Ramsay CF, Deary IJ, Douglas NJ. Self-reported use of CPAP and benefits of CPAP therapy: a patient survey. Chest 1996;109:1470-6.
143. Horstmann S, Hess CW, Bassetti C, Gugger M, Mathis J. Sleepiness-related accidents in sleep apnea patients. Sleep 2000;23:383-9.
144. Suratt P, Findley L. Effect of nasal CPAP treatment on automobile driving simulator performance and on self-reported automobile accidents in subjects with sleep apnea. Am Rev Respir Dis 1992; 145:A169.
145. Cassel W, Ploch T, Becker C, Dugnus D, Peter JH, Von Wichert P. Risk of traffic accidents in patients with sleep-disordered breathing: reduction with nasal CPAP. Eur Respir J 1996;9:2606-11.
146. Yamamoto H, Akashiba T, Kosaka N, Ito D, Horie T. Long-term effects of nasal continuous positive airway pressure on daytime sleepiness, mood and traffic accidents in patients with obstructive sleep apnoea. Respir Med 2000;94:87-90.
147. Graham JD, Thompson KM, Goldie SJ, Segui-Gomez M, Weinstein MC. The cost-effectiveness of air bags by seating position. JAMA 1997; 278:1418-25.
148. Jenkinson C, Davies RJ, Mullins R, Stradling JR. Long-term benefits in self-reported health status of nasal continuous positive airway pressure therapy for obstructive sleep apnoea. QJM 2001;94:95-9.
149. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335:765-74.
150. Waterhouse JC, Brazier JE, Billings CG, et al. Can a two week trial of CPAP treatment return patients' perception of vitality to that of the local population? Eur Respir J 2000;16:S167.
151. Waterhouse JC, Brazier JE, Billings CG, et al. Can a health status questionnaire demonstrate change after a two week trial of CPAP treatment? Eur Respir J 2000;16:S269.
152. Brazier J, Usherwood T, Harper R, Thomas K. Deriving a preference-based single index from the UK SF-36 Health Survey. J Clin Epidemiol 1998;51:1115-28.
153. Clark GT, Blumenfeld I, Yoffe N, Peled E, Lavie P. A crossover study comparing the efficacy of continuous positive airway pressure with anterior mandibular positioning devices on patients with obstructive sleep apnea. Chest 1996;109:1477-83.
154. Briggs A, Claxton K, Sculpher M. Decision modelling for health economic evaluation. Oxford: Oxford University Press; 2006.
155. West SD, Nicoll DJ, Wallace TM, Matthews DR, Stradling JR. The effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes [personal communication].
156. Jenkinson C, Stradling J, Petersen S. Comparison of three measures of quality of life outcome in the evaluation of continuous positive airways pressure therapy for sleep apnoea. J Sleep Res 1997; 6:199-204.
157. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J. Health Econ. 2002; 21:271-92.
158. Chung L-H, Kind P. Exchanging SF-12 to EQ-5D: caveat emptor [submitted to journal]. Med Decis Making 2007.
159. Sullivan PW, Ghushchyan V. Preference-based EQ-5D index scores for chronic conditions in the United States. Med Decis Making 2006; 26:410-20.
160. Currie C, McEwan P, Peters J, Patel TC, Dixon S. The routine collation of health outcomes data from hospital treated subjects in the Health Outcomes Data Repository (HODaR): Descriptive analysis from the first 20,000 subjects. Value Health 2005;8:581-90.
161. Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profiles. Am Heart J 1990;121:293-8.
162. Mora S, Yanek L, Moy T, Fallin D, Becker L, Becker D. Interaction of Body Mass Index and Framingham Risk Score in predicting incident coronary disease in families. Circulation 2005;111:1871-6.
163. Riley R, Abrams K, Lambert P, Sutton AJ, Thompson JR. An evaluation of bivariate random-effects meta-analysis for the joint synthesis of two correlated outcomes. Stat Med 2006;26:78-97.
164. Riley RD, Abrams KR, Sutton AJ, Lambert PC, Thompson JR. Bivariate random effects meta-analysis and the estimation of between-study correlation. BMC Med Res Methodol 2007;7: DOI:10.1186/ 471-2288-7-3.
165. Bucher HC, Guyatt GH, Griffith LE, Walter SD. The results of direct and indirect treatment comparisons in meta-analysis of randomised controlled trials. J Clin Epidemiol 1997;50:683-91.
166. Barbé F, Sunyer J, de la Pena A, Pericas J, Mayoralas LR, Anto JM, et al. Effect of continuous positive airway pressure on the risk of road accidents in sleep apnea patients. Respiration 2007; 74:44-9.
167. Jones L, Griffin S, Palmer S, Main C, Orton V, Sculpher M, et al. Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation. Health Technol Assess 2004;8(38).
168. Chiang CL. Introduction to stochastic processes in biostatistics. New York: John Wiley; 1968.
169. Dennis MS, Burn JP, Sandercock PA, Bamford JM, Wade DT, Warlow CP. Long-term survival after first-ever stroke: the Oxfordshire Community Stroke. Stroke 1993;24:796-800.
170. Rosengren A, Wilhelmsen L, Hagman M, Wedel H. Natural history of myocardial infarction and angina pectoris in a general population sample of middle-aged men: a 16-year follow-up of the Primary Prevention Study, Göteborg, Sweden. J Intern Med 1998;244:495-505.
171. Curtis L, Netten A. Unit costs of health and social care 2006. Personal Social Services Research Unit (PSSRU); 2006. [cited 2007 6 June]. URL: www.pssru.ac.uk/uc/uc2006contents.htm.
172. The Information Centre. NHS dental statistics for England. Quarter 1: 30June 2006. The Information Centre; 2006. [cited 2007 6 June]. URL: www.ic.nhs.uk/pubs/nhsdentq2.
173. Edwards MJ, Brickley MR, Goodey RD, Shephard JP. The cost, effectiveness and cost-effectiveness of removal and retention of asymptomatic, disease-free third molars. Br Dent J 1999;187(7):380-4.
174. Briggs A, Mihaylova B, Sculpher M, Hall A, Wolstenholme J, Simoons M, et al. The cost-effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study [online publication]. Heart 2006: DOI:10.1136/hrt.2005.086728.
175. Bravo-Vergel Y, Palmer S, Asseburg C, Fenwick E, de Belder M, Abrams K, et al. Is primary angioplasty cost-effective in the UK? Results of a comprehensive decision analysis [in press]. Heart 2007.
176. Bonnet MH. ACNS clinical controversy: MSLT and MWT have limited clinical utility. J Clin Neurophysiol 2006;23:50-8.
177. Littner MR, Kushida CA, Wise MS, Davila D, Morgenthaler TI, Lee-Chiong T, et al. Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep 2005;28:113-21.
178. O'Brien E, Asmar R, Beilin L, Imai Y, Mallion JM, Mancia G, et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003;21:821-48.
179. Hoekema A, Stegenga B, De Bout LG. Efficacy and co-morbidity of oral appliances in the treatment of obstructive sleep apnea-hypopnea: a systematic review. Crit Rev Oral Biol Med 2004;15:137-55.
180. Haentjens P, Van Meerhaeghe A, Moscariello A, De Weerdt S, Poppe K, Dupont A, et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome. Arch Intern Med 2007;167:757-65.
181. Evaluation of the application of nocturnal nasal continuous positive airway pressure in the treatment of obstructive sleep apnoea. Paris: Agence Nationale pour le Developpement de l'Evaluation Medicale; 1992. Report No.: ANDEM-92-S-04.
182. Resta O, Guido P, Picca V, Scarpelli F, Foschino MP, Legari G, et al. Bilevel positive pressure (BiPAP) in sleep apnea (SA) patients. Chest 1997;112:S149.
183. Shashikumar RH, Fulambarker A, Crisostomo I, Cohen M. Long-term effectiveness of nasal continuous positive airway pressure in mild sleep apnea compared with conservative measures. Chest 2002; 122:S130.
184. Martinez-Garcia MA, Galiano-Blancart R, Roman-Sanchez P, Soler-Cataluna JJ, Cabero-Salt L, Salcedo-Maiques E. Continuous positive airway pressure treatment in sleep apnea prevents new vascular events after ischemic stroke. Chest 2005;128:2123-9.
185. Adlakha A, Gross PT. Comparison of sleep arousals before and after CPAP titration in patients with obstructive sleep apnea. Sleep 2006; 29:A157.
186. Ahmed T, Zein JG, Younis WG, Ali F, Tawk MM, Kinasewitz GT. Long-term effect of CPAP therapy on blood pressure control in patients with obstructive sleep apnea (OSA). Chest 2005;128:S223.
187. Akashiba T, Minemura H, Horie T. The influence of nasal continuous positive airways pressure (CPAP) on nocturnal hypertension in obstructive sleep apnea (OSA) patients. Sleep 1993; 16:S35-6.
188. Almirall J, Masdeu MJ, Ferrer A, Martinez-Ocana JC, Lopez T, Prats T, et al. Prevalence of obstructive sleep apnea among patients with resistant arterial hypertension. Effects of CPAP on blood pressure. J Hypertens 2005;23:S202.
189. Anonymous. Nasal CPAP reduces day and night blood pressure in obstructive sleep apnea. Cardiology Review 2003;20:9.
190. Antic N, Clark R, Hensley M, Naughton M, Rowland S, Windler S, et al. Assessing neurocognitive function in moderate to severe obstructive sleep apnea before and after CPAP therapy. Sleep 2006; 29:A185.
191. Ayas NT, Mancini GBJ, Fleetham J. Does CPAP delay the development of cardiovascular disease in patients with obstructive sleep apnoea hypopnoea? Thorax 2006;61:459-60.
192. Babar SI, Quan SF. Continuous positive airway pressure: Placebo power, or does it really work? Arch Intern Med 2003;163:519-20.
193. Badia JR, Hernandez L, Leon C, Alarcon A, Ballester E, Rodriguez-Roisin R, et al. Efficacy of CPAP treatment in moderate to severe sleep apnea hypopnea syndrome (SAHS). Eur Respir J 1997;10:S310.
194. Bakshi MS, Hoskere G, Mehta JB, Chidambaram B, Ponder M, Girish MR. Circulatory response in sleep apnea patients during sleep before and after CPAP treatment. Sleep 2005; 28:A194.
195. Barry H. Is nasal continuous positive airway pressure effective in reducing symptoms of obstructive sleep apnea? Evid Based Pract 1999;2:9-10.
196. Becker H, Kohler U, Peter JH, von Wichert P. Nocturnal cardiac-arrhythmias in 78 patients with sleep-apnea under nasal continuous positive airway pressure therapy. In Horne JA, editor. Sleep '88. Stuttgart: Hustav Fischer Verlag; 1989. pp. 268-9.
197. Becker H, Grote L, Ploch T, Schneider H, Stammnitz A, Peter JH, et al. Intrathoracic pressure changes and cardiovascular effects induced by nCPAP and nBiPAP in sleep apnoea patients. J Sleep Res 1995; 4:125-9.
198. Beecroft JM, Zanon S, Lukic D, Hanly PJ. Oral CPAP for sleep apnea: Effectiveness, patient preference and compliance. Sleep 2003; 26:A209-10.
199. Berka C, Westbrook PR, Lumicao MN, Olmstead R, Levendowski DJ, Davis G, et al. Influence of sleep-disordered breathing on neurocognitive functions pre- and posttreatment with CPAP. Sleep 2006; 29:A208-9.
200. Bloch MJ, Basile J. Short-term treatment of sleep apnea with nocturnal continuous positive airway pressure does not improve blood pressure in patients with well controlled hypertension. J Clin Hypertens 2006;8:673-5.
201. Bradley TD, Takasaki Y, Orr D, Popkin J, Liu P, Rutherford R. Sleep apnea in patients with left ventricular dysfunction: beneficial effects of nasal CPAP. In Issa FG, Suratt PM, Remmers JE, editors. Sleep and respiration: proceedings of the first International Symposium on Sleep and Respiration held in Banff, Alberta, April 1-4, 1989. New York, NY: Wiley-Liss; 1990. pp. 363-70.
202. Braghiroli A, Sacco C, Carli S, Rossi S, Donner CF. Autocontinuous positive airway pressure in the diagnosis and treatment of obstructive sleep apnoea. Monaldi Arch Chest Dis 1998;53:621-4.
203. Buechner NJ, Zidek W, Esser M, Haske M, Sanner BM. Obstructive sleep apnea syndrome. Effects of therapy on dyslipidemia. Somnologie 2001;5:97-102.
204. Buttner A, Ruhle KH. Quality of life before and during nCPAP. Comparison of different questionnaires - SWLS, MLDL and SF-36. Pneumologie 2004;58:651-9.
205. Castronovo VE, Baietto C, Castaldi P, Di Gioia MR, Zucconi M, Ferini-Strambi L. Obstructive sleep apnea syndrome and cognitive functions: the effect of CPAP treatment. Sleep 2003; 26:A252-3.
206. Chakravorty I, Sapiano S, Ruprai M, Cayton R. Quality of life in patients on long term continuous positive airway pressure for obstructive sleep apnoea. Thorax 1998;53:S12.
207. Chasens ER, Weaver TE, Maislin G, Dinges D, Pack A. Sleepiness and adherence to CPAP treatment in adults with OSA. Sleep 2003; 26:A256.
208. Chazan R, Bielicki P, Byskiniewicz K, Rubinsztajn R, Kumor M. The influence of 8 months of therapy with nasal continuous positive airway pressure (NCPAP) on leptin serum concentration and sympathetic activity in patients with obstructive sleep apnea syndrome (OSAS). Chest 2004;126:S905.
209. Chrysostomakis SI, Simantirakis EN, Marketou ME, Schiza SE, Mavrakis HE, Klapsinos NC, et al. Effects of continuous positive airway pressure therapy on autonomic nervous system activity in patients with obstructive sleep apnoea hypopnoea syndrome. Eur Heart J 2004; 25:572.
210. Ciftci TU, Ciftci B, Guven SF, Kokturk O, Turktas H. Effect of nasal continuous positive airway pressure in uncontrolled nocturnal asthmatic patients with obstructive sleep apnea syndrome. Respir Med 2005; 99:529-34.
211. Deegan PC, McNicholas WT. Effects of (nCPAP) on cardiac function awake and asleep. J Sleep Res 1995;4:59-63.
212. Dhillon S, Chung SA, Fargher TJ, Shapiro CM. CPAP decreases blood pressure in sleep apnea patients with hypertension. Sleep 2003; 26:A217.
213. Donadio V, Montagna P, Vetrugno R, Contin M, Falzone F, Baruzzi A, et al. CPAP treatment lowers sympathetic nerve activity and blood pressure in hypertensive obstructive sleep apnoea patients. J Neurol 2006;253(Suppl. 2):158.
214. Dorkova Z, Tkacova R. Initiating treatment with auto-CPAP in patients with severe obstructive sleep apnea and arterial hypertension: effects on systemic blood pressure and heart rate. J Sleep Res 2006; 15:198.
215. Douglas NJ, Engleman HM. CPAP therapy: outcomes and patient use. Thorax 1998;53:S47-8.
216. Douglas NJ. Treatment of the obstructive sleep apnea/hypopnea syndrome: the effect on blood pressure. Sleep 2004;27:842-3.
217. Drummond FE, Doelken P, Frye MD. Empiric treatment of clinically diagnosed obstructive sleep apnea using auto-titrating continuous positive airway pressure. Chest 2005;128:S223.
218. Engleman HM, Cheshire KE, Deary IJ, Douglas NJ. Daytime sleepiness, cognitive performance and mood after continuous positive airway pressure for the sleep apnoea/hypopnoea syndrome. Thorax 1993; 48:911-14.
219. Engleman HM. When does 'mild' obstructive sleep apnea/hypopnea syndrome merit continuous positive airway pressure treatment? Am J Respir Crit Care Med 2002;165:743-5.
220. Fairbairn SEA, Richards J, Gregory M, Hack M. The effect of continuous positive airway pressure and mandibular advancement splint therapy on steering simulation in obstructive sleep apnoea syndrome (OSAS) [abstract online]. American Thoracic Society; 2006. [cited 2007 29 May]. URL: www.abstracts2view.com/ats06/.
221. Ficker JH, Fischer C, Wiest GM, Lehnert G, Hahn EG. Efficacy of auto-CPAP in the treatment of obstructive sleep apnoea syndrome (OSA). Eur Respir J 1997;10:S189.
222. Ficker JH, Clarenbach CF, Neukirchner C, Fuchs FS, Wiest GH, Schahin SP, et al. Efficacy and compliance of autoadjusting CPAP therapy based on the forced oscillation technique. Am J Respir Crit Care Med 2002;165:B21.
223. Fitzpatrick MF, Driver HS, Willing S, San PM. Does continuous positive airway pressure (CPAP) after nasal resistance [Abstract online]. American Thoracic Society; 2005. [cited 2007 29 May]. URL: www.abstracts2view.com/ats05/.
224. Flemons W, Lowe A, Vazquez JC, Ferguson K, Remmers J, Fleetham J. Quality of life in patients with obstructive sleep apnea treated either with an oral appliance or CPAP. Am J Respir Crit Care Med 1998; 157:A53.
225. Fletcher EC. Cardiovascular effects of continuous positive airway pressure in obstructive sleep apnea. Sleep 2000;23:S154-7.
226. Gagnadoux F. The mandibular advancement splint: a true therapeutic alternative. Rev Mal Respir 2006;23:7S51-4.
227. Golish JA. Therapeutic NCPAP was more effective than subtherapeutic NCPAP in obstructive sleep apnea. Commentary on Jenkinson C, Davies RJ, Mullins R et al. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet 1999 Jun 19;353:2100-5. ACP J Club 2000;132:16.
228. Goncalves MA, Guilleminault C, Ramos E, Palha A, Paiva T. Erectile dysfunction, obstructive sleep apnea syndrome and nasal CPAP treatment. Sleep Med 2005;6:333-9.
229. Gotsopoulos H, Chen C, Qian L, Cistulli PA. Oral appliance therapy improves symptoms in obstructive sleep apnea: a randomized, controlled trial. Am J Respir Crit Care Med 2002;166:743-8.
230. Grimm W, Koehler U, Fus E, Hoffmann J, Menz V, Funck R, et al. Outcome of patients with sleep apnea-associated severe bradyarrhythmias after continuous positive airway pressure therapy. Am J Cardiol 2000;86:688-92.
231. Hahn PY, Hauri PJ, Sahai A, Staats BA. Insomnia and obstructive sleep apnea (OSA): evaluation and CPAP therapy. Sleep 2003; 26:A300-1.
232. Hermida RC, Zamarron C, Ayala DE, Fontao MJ, Ricoy J, Calvo C. Continuous positive airway pressure therapy has no effect on nocturnal blood pressure in patients with obstructive sleep apnea. J Hypertens 2003;21:111.
233. Hermida RC, Zamarron C, Ayala DE, Fontao MJ, Ricoy J, Calvo C. Effect of continuous positive airway pressure therapy on ambulatory blood pressure in patients with obstructive sleep apnea. Am J Hypertens 2003; 16:A52, P-377.
234. Hermida RC, Zamarron C, Ayala DE, Calvo C. Effect of continuous positive airway pressure on ambulatory blood pressure in patients with obstructive sleep apnoea. Blood Press Monit 2004;9:193-202.
235. Hernandez L, Farre R, Ballester E, Navajas D, Montserrat JM. Compliance of sham-cpap compared with optimal cpap in sleep apnea syndrome. Eur Respir J 1999;14:P2705.
236. Hetzel C, Weess HG, Schroeder A, Steinberg R. Parameters of subjective well-being of obstructive sleep apnea patients before and after nCPAP-therapy. Wien Med Wochenschr 1994;145:510-11.
237. Hira. HS. Obstructive sleep apnea syndrome: evaluation of subcritical continuous positive airway pressure. J Assoc Physicians India 1998;46:796-7.
238. Hirshkowitz M, Sharafkhaneh A. Positive airway pressure therapy of OSA. Semin Respir Crit Care Med 2005;26:68-79.
239. Hla KM, Skatrud JB, Finn L, Palta M, Young T. The effect of correction of sleep-disordered breathing on BP in untreated hypertension. Chest 2002;122:1125-32.
240. Hoster M, Schlenker E, Ruhle KH. Influence of automated self-setting CPAP-devices on sleep and breathing in sleep apnea syndrome. In Schlafke ME, editor. Leistung and Schlaf: Beitrage zum 3 Kongre- der Deutschen Geseltschaft fur Schlafforschung and Schlafmedizin (DGSM) vom 19 bis 21 Oktober 1995 an der Ruhr-Universitat Bochum; 1995 Oct; Bochum; Germany. Wien; 1995. pp. 385-6.
241. Huang R, Huang XZ, Xiao Y. Evaluation of an auto-CPAP device for treatment of obstructive sleep apnea. Beijing Med J 2001; 23:350-2.
242. Iellamo F, Montana N. Continuous positive airway pressure treatment: Good for obstructive sleep apnea syndrome, maybe not for hypertension? Chest 2006;129:1403-5.
243. Itzhaki S, Pillar G, Lavie P, Lavie L. Endothelial function of patients with obstructive sleep apnea improves following 3 months on CPAP. J Sleep Res 2006;253(Suppl. 2):A158.
244. Juhasz J, Cassel W, Gutheil T, Becker H, Peter JH. Proportional positive airway pressure for the therapy of obstructive sleep apnea (OSA). Eur Respir J 1997;10:S189.
245. Kajaste S, Brander PE, Telakivi T, Partinen M, Mustajoki P. A cognitive-behavioral weight reduction program in the treatment of obstructive sleep apnea syndrome with or without initial nasal CPAP: a randomized study. Sleep Med 2004;5:125-31.
246. Kaleth AS, Chittenden TW, Hawkins BJ, Gregg JM, Zedalis D, Pierson LM, et al. The effects of nCPAP therapy and aerobic exercise on daytime heart rate variability in patients with obstructive sleep apnea. Sleep 2003;26:A236.
247. Kaleth A, Chittenden TW, Hawkins BJ, Hargens TA, Guill S, Zedalis D, et al. Nasal CPAP therapy and aerobic exercise training: effects on the heart rate response to graded exercise in obstructive sleep apnea patients. Sleep 2005;28:A206-7.
248. Karacan I, Karatas M. Erectile dysfunction in sleep apnea and response to continuous positive airway pressure. In: Annual Meeting of the American Psychiatric Association; 1995; Miami, FL. American Psychiatric Association; 1995. p. NR435.
249. Kiely JL, Murphy M, McNicholas WT. Subjective efficacy of nasal CPAP therapy in obstructive sleep apnoea syndrome: a prospective controlled study. Eur Respir J 1999;13:1086-90.
250. Konermann M, Sanner B, Klewer J, Kreuzer I, Laschewski F, Burmann-Urbanek M. Changes of cardiac and pulmonary performance indices under nCPAP-therapy in patients with obstructive sleep apnea. In Schlafke ME, editor. Leistung and Schlaf: Beitrage zum 3 Kongre- der Deutschen Gesellschaft fur Schlafforschung und Schlafmedizin (DGSM) vom 19 bis 21 Oktober 1995 an der Ruhr-Universitat Bochum; 1995 Oct; Bochum; Germany. Wien; 1995. pp. 340-3.
251. Krieger J, Racineux JL, Huber P, Sautegeau A, Redondo J, Castaing Y, et al. A multicenter trial of a device for treating obstructive sleep apnea by continuous positive pressure. Bull Eur Physiopathol Respir 1986;22:393-7.
252. Lafond C, Series E. Lemiere C. Impact of continuous positive airway pressure (CPAP) on airway responsiveness and asthma quality of life in subjects with asthma and sleep apnea syndrome. Chest 2005; 128:S165-6.
253. Lafond C, Series E, Lemiere C. Impact of CPAP on asthmatic patients with obstructive sleep apnoea. Eur Respir J 2007;29:307-11.
254. Lewis KE, Watkins AJ, Seale L, Bartle IE, Ebden P. Continuous positive airways pressure (CPAP) treatment can reduce anxiety and depression in obstructive sleep apnoea. Thorax 2002;57:P57.
255. Li F, Feng Q, Zhang X, Liu Q. Treatment for erectile dysfunction patients with obstructive sleep apnea syndrome by nasal continual positive airway pressure. Zhong Hua Nan Ke Xue 2004; 10:355-7.
256. Litvin A, Pevzner AV, Golitsyn PV, Galiavi RA, Mazygula EP, Nesterenko L, et al. New approaches to treatment of bradyarrhythmia in patients with obstructive sleep apnea syndrome. Ter Arkh 2006; 78:41-7.
257. Logan AG, Tkacova R, Perlikowski SM, Leung RS, Tisler A, Floras JS, et al. Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex. Eur Respir J 2003;21:241-7.
258. Mador MJ, Krauza M, Pervez A, Pierce D, Braun M. Effect of heated humidification on nasal CPAP compliance and quality of life in patients with sleep apnea. In American Thoracic Society International Conference; 2005; San Diego, CA. American Thoracic Society; 2005. p. [C58] [Poster: C2]. URL: www.abstracts2view.com/ats05/.
259. Malow B. Effects of treating obstructive sleep apnea in epilepsy [online project record]. National Library of Medicine; 2005 [cited 2007 29 May]. URL: www.clinicaltrials.gov/ct/show/NCT00047463.
260. Marrone O, Milone E, Ferrara G, Romano L, Bellia V. Transmural pulmonary artery pressure during CPAP in obstructive sleep apnoea syndrome. Eur Respir J 1990;11:S544-5.
261. Marshall MJ, Coughlin SR. Does positive airway pressure therapy (PAP) provide a symptomatic benefit at low levels of compliance in obstructive sleep apnoea patients? Thorax 2004;59(Suppl. 2):15.
262. Mayer J, Weichler U, Cassel W. Ploch T, Peter JH, von Wichert P. Does placebo treatment lower nocturnal blood pressure in patients with sleep-related breathing disorders and arterial hypertension? Cardiology 1993;82:69-78.
263. McArdle N, Kingshott R, Engleman HM, Mackay TW, Douglas NJ. Partners of patients with sleep apnoea/hypopnoea syndrome: effect of CPAP treatment on sleep quality and quality of life. Thorax 2001; 56:513-18.
264. McEvoy RD, Thornton AT. Treatment of obstructive sleep apnea syndrome with nasal continuous positive airway pressure. Sleep 1984; 7:313-25.
265. McFadyen TA, Espie CA, McArdle N, Douglas NJ, Engleman HM. Controlled, prospective trial of psychosocial function before and after continuous positive airway pressure therapy. Eur Respir J 2001; 18:996-1002.
266. McNab BD, Dang B, Cotton D, Skomro R, Gjevre J, Reid J. Patient satisfaction with empiric CPAP therapy for suspected obstructive sleep apnea. Sleep 2006;29:A215.
267. Morrish R, Shneerson JM, Smith IE. Comparison of mortality risk between men and women using CPAP for obstructive sleep apnea. Sleep 2004;27:A212.
268. Mulgrew AT, Fox N, Ayas NT, Ryan CF. Diagnosis and initial management of obstructive sleep apnea without polysomnography. Ann Intern Med 2007;146:157-66.
269. Nagasaka Y, Nambu Y, Fujita E, Hazu R, Yoshida M, Ikeshita K. Comparison of the effect of nasal CPAP and mandibular advancement splint (MAS) in patients with obstructive sleep apnea (OSA). Eur Respir J 1997; 10:S188.
270. Newsom-Davis IC, Lyall RA, Leigh PN, Moxham J, Goldstein LH. The effect of non-invasive positive pressure ventilation (NIPPV) on cognitive function in amyotrophic lateral sclerosis (ALS): a prospective study. J Neurol Neurosurg Psychiatry 2001;71:482-7.
271. Nooman YM, Hamid S, Woolford M, Sutton A. Experience with mandibular repositioning in the treatment of snoring and the obstructive apnoea-hypopnoea syndrome with and without nasal continuous positive airway pressure (N-CPAP). Thorax 1998;53:S16.
272. Pepin J, Baguet J, Lebrun M, Levy P, Pierre H, Peeters M, et al. Obstructive sleep apnea syndrome and left ventricular diastolic function: effects of nasal continuous positive airway pressure (CPAP). J Sleep Res 2006;15:202.
273. Phillips BA, Schmitt FA, Berry DT, Lamb DG, Amin M, Cook YR. Treatment of obstructive sleep apnea. A preliminary report comparing nasal CPAP to nasal oxygen in patients with mild OSA. Chest 1990; 98:325-30.
274. Poluektov MG, Eligulashvili TS. Long-term positive air pressure in the treatment of sleep apnea syndrome. Ter Arkh 1994;66:85-7.
275. Risk CG, Winzer JA. Impact of continuous positive airway pressure treatment on attention deficit in obstructive sleep apnea. Chest 2004;126:S785.
276. Rosenthal LD, Meixner RM, Schmidt-Nowara WW, Becker PM, Jamieson AO. The functional status outcome of OSA patients after two weeks of CPAP therapy. Sleep 2003;26:A254.
277. Rosenthal L, Dolan DC, Taylor DJ. Response to CPAP therapy in sleepy and non-sleepy OSA patients. Sleep 2006;29:A211.
278. Sakakibara H. Treatment of sleep apnea syndrome with oral appliances. Kokyu To Junkan 2005;53:301-8.
279. Sanders MH, Strollo PJ. Positive airway pressure in the treatment of sleep-related breathing disorders. Semin Respir Crit Care Med 1998;19:147-56.
280. Sanders MH. Article reviewed: daytime sleepiness and EEG spectral analysis in apneic patients before and after treatment with continuous positive airway pressure. Sleep Med 2001;2:263-5.
281. Sanner B, Fluerenbrock N, Kleiber-Imbeck A, Mueller J, Zidek W. Effect of CPAP therapy on infectious complications in patients with OSAS. Eur Respir J 2000;16:S268.
282. Sanner B, Markmann A, Zidek W, Tepel M. Continuous positive airway pressure therapy reduces blood pressure in hypertensive patients with obstructive sleep apnea - a prospective study. J Hypertens 2003; 21:S272.
283. Schutte-Rodin S, Spencer G, Stache S, Colleen B, Staley B, Katzka D, et al. Defining and scoring gastroesophageal reflux events in obstructive sleep apnea patients during polysomnography with and without CPAP. Sleep 2006;29:A305.
284. Seiler SC, Keller M, Hurlimann U, Klinger K, Brandli O. Effect of CPAP-therapy on neuropsychological functioning in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 1998;157:A52.
285. Shadan F, Jalowayski AA, Kline LE, Dawson A. Nasal inflammation and carriage of Staphylococcus aureus in patients with obstructive sleep apnea treated with nasal CPAP. Sleep 2006;29:A193-4.
286. Shimizu M, Tachibana N, Nagasaka Y, Goto M. Obstructive sleep apnea (OSA) in RA patients and effect of CPAP on RA activity. Arthritis Rheum 2003;48:S114.
287. Skomro RP, King L, Mink J. Efficacy and safety of empiric continuous positive airway pressure therapy in subjects with obstructive sleep apnea. Chest 2003;124(4):S227.
288. Smith LJ, Skrekas JE, Arnedt J, Millman RP, Stanchina M, Aloia MS. CPAP use predicts change in depressive symptoms 3 months post-treatment in obstructive sleep apnea (OSA). Sleep 2005;28:A209.
289. Stammnitz A, Becker H, Schneider H, Peter JH, Wichert PV. Risks and complications during positive airway pressure treatment of obstructive sleep apnea. Pneumologie 1993;49:190-4.
290. Stoohs RA, Facchini FS, Philip P, Valenciaflores M, Guilleminault C. Selected cardiovascular risk-factors in patients with obstructive sleep-apnea - effect of nasal continuous positive airway pressure (N-Cpap). Sleep 1993;16:S141-2.
291. Suhner AG, Darko DD, Erman MK, Riel KF, Mitler MM. Depressive symptoms in patients with OSA and the impact of nasal CPAP treatment. Sleep 2003;26:A225.
292. Veale D, Cornette A, Joet FP, Pepin JL, Escourrou P, Meurice JC. Evaluation of CPAP efficacy in long term home treatment for obstructive sleep apnea syndrome. American Thoracic Society; 2003 [cited 2007 29 May]. URL: www.abstracts2view.com/atsall/.
293. Verbraecken JA, Willemen M, Van de Heyning P, De Backer WA. Daytime lung inflation after bilevel positive airway pressure therapy (bipap) in obstructive sleep apnea with and without overlapsyndrome. Eur Respir J 2002;20:S100.
294. Voronin IM, Belov AM, Chuchalin AG. Placebo-controlled study of a short-term hypotensive effect of intranasal ventilation with continuous positive airway pressure therapy in patients with arterial hypertension stage I. Ter Arkh 2002;74:25-30.
295. Weaver T. Impact of CPAP on functional outcomes in milder obstructive sleep apnea (CATNAP) [project record online]. National Library of Medicine; 2004. [cited 2007 29 May]. URL: clinicaltrials.gov/ct/show/ NCT00089752.
296. Weisfogel GM, Ash CE, Walters AS. Nocturnal angina caused by OSA with symptoms relieved by positive airway pressure. Sleep 2003; 26:A237.
297. Weissenberg A, Zulley J, Bauer M. The influence of CPAP-treatment on stress coping and well-being sleep apnea patients. Wien Med Wochenschr 1994;145:523-4.
298. Westbrook PR. Treatment of sleep disordered breathing: nasal continuous positive airway pressure (CPAP). Prog Clin Biol Res 1990; 345:387-93.
299. Westbrook PR, Berka C, Levendowski DJ, Lumicao M, Davis G, Olmstead R, et al. Quantification of alertness, memory and neurophysiological changes in sleep apnea patients following treatment with nCPAP. Sleep 2004;27:A223.
300. Wiest GH, Ficker JH, Lehnert G, Hahn EG. Prospective, randomised, placebo-controlled study on the effectiveness of a heated humidifier in the therapy of dry upper respiratory tracts under nCPAP by OSAS. Pneumologie 1998;52:S60.
301. Woodson BT, Steward DL, Weaver EM. Outcomes of non-attended home autosetting CPAP titration. Sleep Med 2003;4(Suppl. 1):S53.
302. Woodson BT, Steward DL, Weaver EM, Javaheri S. A randomized trial of temperature-controlled radiofrequency, continuous positive airway pressure, and placebo for obstructive sleep apnea syndrome. Otolaryngol Head Neck Surg 2003;128:848-61.
303. Worsnop C, Naughton M, Barter C, Morgan T, Anderson A, Pierce R. Blood pressure and humoral effects of nasal continuous positive airway pressure (NCPAP) in hypertensives with obstructive sleep apnoca (OSA). Aust N Z J Med 1994;24:480.
304. Yen FC, Behbehani K, Burk JR, Lucas EA, Axe J. Long term performance evaluation of an automatic airway positive pressure device. Proceedings of the 18th Annual International Conference of the IEEE Engineering in Medicine and Biology Society 1997;18:2113-14.
305. Zimmerman ME, Arnedt J, Skrekas J, Harris S, Smith L, Aloia MS. The relationship between time-on-CPAP and vigilance in sleep apnea at baseline, 3-months, and 6-months. Sleep 2005;28:A170.
306. Doff MH, Hoekema A, Stegenga B, Bakker M, Brouwer WH, de Bont LG, et al. Effectiveness of oral appliances and continuous positive airway pressure on simulated driving performance in obstructive sleep apnea-hypopnea syndrome: a randomised trial. Sleep Med 2006; 7:S90.
307. Alonso-Fernandez A, Arias MA, Garcia-Rio F, Ramirez M, Fernandez-Lahera J. Impaired left ventricular performance during exercise in patients with obstructive sleep apnea-hypopnea syndrome improves with continuous positive airway pressure [Poster abstract 5231. In American Thoracic Society International Conference; 2005 May 20-25; San Diego, CA. American Thoracic Society; 2005. p. D27. URL: www.abstracts2view.com/ ats05/.
308. Bardwell WA, Loredo JS, Lim W, Ancoli-Israel S, Dimsdale JE. Effects of two-weeks nocturnal oxygen supplementation and continuous positive airway pressure treatment on psychological symptoms in patients with obstructive steep apnea: a randomized placebo-controlled study. Sleep 2005;28:A160.
309. Arias MA, Alonso-Fernandez A, Garcia-Rio F, Santiago A, Lores V. Obstructive sleep apnea is independently associated with daytime pulmonary arterial hypertension that improves with continuous positive airway pressure treatment [Poster abstract 526]. In American Thoracic Society International Conference; 2005 May 20-25; San Diego, CA. American Thoracic Society; 2005. p. D27. URL: www.abstracts2view.com/ ats05/.
310. Arias MA, Alonso-Fernandez A, Garcia-Rio F, Mediano O, Rojo B. Obstructive sleep apnea syndrome affects left ventricular diastolic function effects on nasal continuous positive airway pressure [Poster abstract 525]. In American Thoracic Society International Conference; 2005 May 20-25; San Diego, CA. American Thoracic Society; 2005. p. D27. URL: www.abstracts2view.com/ats05/view.php?nu=ATS5L_1594.
311. Becker H, Jerrentrup A, Ploch T, Grote L, Penzel T, Peter JH. Prospective randomized study on the effect of therapeutic and subtherapeutic nasal continuous positive airway pressure (NCPAP) treatment on blood pressure in obstructive sleep apnea (OSA). Am J Respir Crit Care Med 2001;163:A838.
312. Chakravorty I, Cayton RM, Szczepura A. Cost effectiveness analysis of nasal CPAP and lifestyle intervention in obstructive sleep apnoea. Thorax 2001;56:27-8.
313. Coughlin SR, Mugarza JA, Mawdsley L, Wilding JP, Calverley PM. Continuous positive airways pressure treatment reduces the cardiovascular risk factors associated with obstructive sleep apnoea [Poster abstract 111]. In American Thoracic Society 100th International Conference; 2004 May 21-26; Orlando, FL. American Thoracic Society; 2004. p. C99. URL: www.abstracts2view.com/ats/.
314. Cross MD, Al-Abri M, Newby DE, Riba R, Vennelle M, Douglas NJ. Randomised controlled trial evidence that continuous positive airway pressure improves vascular function in obstructive sleep apnoea hypopnoea syndrome. Thorax 2005;60(Suppl. 2):S117.
315. Profant J, Ancoli-Israel S, Dimsdale JE. A randomized, controlled trial of 1 week of continuous positive airway pressure treatment on quality of life. Heart Lung 2003;32:52-8.
316. Bao X, Nelesen RA, Loredo JS, Dimsdale JE, Ziegler MG. Blood pressure variability in obstructive sleep apnea: role of sympathetic nervous
317. Ziegler MG, Mills PJ, Loredo JS, Ancoli-Israel S, Dimsdale JE. Effect of continuous positive airway pressure and placebo treatment on sympathetic nervous activity in patients with obstructive sleep apnea. Chest 2001;120:887-93.
318. Nelesen RA, Yu H, Ziegler MG, Mills PJ, Clausen JL, Dimsdale JE. Continuous positive airway pressure normalizes cardiac autonomic and hemodynamic responses to a laboratory stressor in apneic patients. Chest 2001;119:1092-101.
319. Yu BH, Ancoli-Israel S, Dimsdale JE. Effect of CPAP treatment on mood states in patients with sleep apnea. J Psychiatr Res 1999; 33:427-32.
320. Loredo JS, Ancoli-Israel S, Dimsdale JE. Effect of continuous positive airway pressure vs placebo continuous positive airway pressure on sleep quality in obstructive sleep apnea. Chest 1999;116:1545-9.
321. Engleman H, McDonald J, Graham D, Lello G, Douglas N. Randomized controlled crossover trial of CPAP vs MRS therapy for the sleep apnea/ hypopnea syndrome Am J Respir Crit Care Med 2001;163:A837.
322. Faccenda J, Boon N, Mackay T, Douglas N. Quality of life on and off CPAP in patients with sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 2000;161:A714.
323. Faccenda JF, Boon NA, Douglas NJ. Randomised trial of CPAP on blood pressure in SAHS. Am J Respir Crit Care Med 1999;159:A527.
324. Hui DS, To KW, Ko FW, Fok JP, Chan MC, Ngai JC, et al. A randomized subtherapeutic CPAP controlled study of the effects of nasal CPAP on 24-hour systemic blood pressure in obstructive sleep apnoea syndrome. In American Thoracic Society International Conference; 2006 May 19-24; San Diego, CA. American Thoracic Society; 2006. p. A870. URL: www.abstracts2view.com/ats06/.
325. Hack M, Choi R, Mullins R, Dow S, Davies RJ, Stradling JR. Performance of patients with obstructive sleep apnoea (OSA) on a steering simulation after six months treatment with nasal continuous positive airway pressure (NCPAP). Thorax 1999;54:S36.
326. Hack MA, Davies RJ, Stradling JR. Randomised, sham placebo, parallel study of the effect of nasal continuous positive airway pressure (NCPAP) on steering performance in patients with obstructive sleep apnoea (OSA) - interim analysis. Thorax 1998;53:A44.
327. Stradling JR, Jenkinson C, Davies RJ, Mulllins B. Randomised, sham-placebo controlled, parallel study of nasal continuous positive airway pressure (NCPAP) for the treatment of obstructive sleep apnea [abstract]. Am J Respir Crit Care Med 1998;157:A344.
328. Stradling JR, Jenkinson C, Davies RJ, Mullins B. Randomised, sham-placebo, parallel study of nasal continuous positive airway pressure (NCPAP) for the treatment of obstuctive sleep apnoea (OSA). Thorax 1998;53:A3.
329. Hack MA, Davies RJO, Mullins R, Stradling JR. Randomised, sham placebo controlled study of nasal continuous positive airway pressure (NCPAP) on simulated steering in obstructive sleep apnoea (OSA). Am J Respir Crit Care Med 1999;159:A429.
330. Stradling JR, Jenkinson C, Davies RJ, Mullins B. Randomised, sham placebo controlled, parallel study of nCPAP on quality of life (SF36) in obstructive sleep apnoea. Am J Respir Crit Care Med 1999; 159:A770.
331. Lam B, Sam K, Orth M, Mok W, Lam J, Yam L, et al. A randomized study of three non-surgical treatment options in mild to moderate obstructive sleep apnea. In American Thoracic Society International Conference; 2005 May 20-25; San Diego, CA. American Thoracic Society; 2005. p. B18. URL: www.abstracts2view.com/ats05/.
332. Lam B, Sam K, Cheung MT, Mok W, Lam J, Tsang KWF, et al. A randomized controlled study for the treatment of mild/moderate onstructive sleep apnea (OSA). Sleep Med 2003;4:S26.
333. Campbell AJ, Marshall NS, Sheppard DS, Neil AM. Randomised placebo controlled trial of humidified CPAP in mild obstructive sleep apnoea (OSA). Respirology 2004;9:A17.
334. Marshall N, Sheppard DS, Campbell AJ, Neill AM. Randomised controlled crossover trial of continuous positive airway pressure in the treatment of mild-moderate obstructive sleep apnoea using a mechanical placebo. Intern Med J 2004;34:A22.
335. Vidal S, Navarro A, Duran J, Bariera R, Carmona C, Botebol G, et al. Effectiveness of CPAP in mild sleep apnea/hypopnea syndrome (SAHS) compared with conservative treatment. Eur Respir J 2000; 16:S269.
336. Loredo JS, Ancoli-Israel S, Kim EJ, Lim WJ, Dimsdale JE. Effect of continuous positive airway pressure versus supplemental oxygen on sleep quality in obstructive sleep apnea: a placebo-CPAP-controlled study. Sleep 2006;29:564-71.
337. Mills PJ, Kennedy BP, Loredo JS, Dimsdale JE, Ziegler MG. Effects of nasal continuous positive airway pressure and oxygen supplementation on norepinephrine kinetics and cardiovascular responses in obstructive sleep apnea. J Appl Physiol 2006;100:343-8.
338. von Kanel R, Loredo JS, Ancoli-Israel S, Dimsdale JE. Association between sleep apnea severity and blood coagulability: treatment effects of nasal continuous positive airway pressure. Sleep Breath 2006; 10:139-46.
339. Loredo JS, Ancoli-Israel S, Kim E, Lim W, Dimsdale JE. Effect of continuous positive airway positive airway pressure and supplemental oxygen on sleep quality in obstructive sleep apnea: a placebo-CPAP controlled study. Sleep 2005;28:A189.
340. Bardwell WA, Norman D, Ancoli-Israel S, Loredo JS, Lowery A, Lim W, et al. Effects of 2-week nocturnal oxygen supplementation and continuous positive airway pressure treatment on psychological symptoms in patients with obstructive sleep apnea: a randomized placebo-controlled study. Behav Sleep Med 2007;5:21-38.
341. Lim W, Loredo JS, Kim E, Ancoli-Israel S, Morgan EE, Heaton RK, et al. Neuropsychological effects of two week continuous positive airway pressure treatment and supplemental oxygen in patients with obstructive sleep apnea: a randomized controlled study. J Clin Sleep Med 2007;3(4):380-6.
342. Pepperell JC, Mullins B, Dow SR, Crosthwaite N, Stradling JR, Davies RJ. Blood pressure change after treatment for obstructive sleep apnoea (OSA) with continuous positive airway pressure (CPAP). Thorax 2000; 55:A24.
343. Pepperell JC. Obstructive sleep apnoea and cardiovascular risk: the effects of nasal continuous positive airway pressure therapy [MD]. Cambridge: Cambridge University; 2005.
344. Randerath W, Heise M, Galetke W, Hinz R, Ruhle KH. Prospective randomised comparison of a three-dimensional variable protrusion splint with CPAP in mild obstructive sleep apnoea syndrom (OSAS). Pneumologie 2001;55:S73.
345. Robinson GV, Smith DM, Langford BA, Davies RJ, Stradling JR. CPAP does not reduce 24 hour blood pressure in hypertensive obstructive sleep apnoea patients without daytime sleepiness. Thorax 2004; 59(Suppl. 2):16.
346. Tan YK, L'Estrange PR, Grant HR, Smith C, Simonds AK, Spiro SG. A randomised crossover study of continuous positive airway pressure (CPAP) vs mandibular advancement splint (MAS) in mild and moderate obstructive sleep apnoea (OSA). Thorax 1998;53:S13.
347. Tan YK, L'Estrange PL, Grant HR, Smith C, Simonds AK, Spiro SG. A randomised crossover study of continuous positive airway pressure (CPAP) vs mandibular advancement splint (MAS) in mild and moderate obstructive sleep apnoea (OSA). Eur Respir J 1998;12:S5.
348. Tan YK, L'Estrange PR, Grant HR, Smith C, Simonds AK, Spiro SG. Subjective assessment of continuous positive airway pressure (CPAP) and a mandibular advancement splint (MAS) in a randomised crossover study of patients with mild or moderate obstructive sleep apnoea (OSA). Thorax 1998;53:A4.
349. Jenkinson C, Stradling J, Petersen S. How should we evaluate health status? A comparison of three methods in patients presenting with obstructive sleep apnoea. Qual Life Res 1998;7:95-100.